Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B

Since its introduction in the 1990s, liposomal amphotericin B (LAmB) continues to be an important agent for the treatment of invasive fungal diseases caused by a wide variety of yeasts and molds. This liposomal formulation was developed to improve the tolerability of intravenous amphotericin B, whil...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Infect Dis
Главные авторы: Groll, Andreas H, Rijnders, Bart J A, Walsh, Thomas J, Adler-Moore, Jill, Lewis, Russell E, Brüggemann, Roger J M
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2019
Предметы:
Supplement Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6495018/
https://ncbi.nlm.nih.gov/pubmed/31222253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz076
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы